Studies on the efficacy of pyrotinib in the treatment of HER-2 positive advanced solid tumors.

被引：0
|
作者：
Fan, Shaoshuang
Jiang, Da
Lv, Yalei
Cui, Yanzhi
Kong, Yan
Dong, Qian
Huang, Fang
Zhang, Xue
Wang, Long
Zhou, Xinliang
Jin, Hui
Li, Ying
Hou, Ran
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15639
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and tolerability of neratinib in advanced HER-2 positive breast cancer: A single institution experience
    Shepherd, S. T. C.
    Lee, K.
    Mohammed, K.
    Patel, K.
    Allen, M.
    Johnston, S. R. D.
    Parton, M.
    Ring, A.
    Turner, N.
    Okines, A. F. C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] MyPathway HER2 basket study: Pertuzumab (P) plus trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors.
    Meric-Bernstam, Funda
    Hainsworth, John
    Bose, Ron
    Burris, Howard A., III
    Friedman, Claire Frances
    Kurzrock, Razelle
    Swanton, Charles
    Wang, Yong
    Levy, Jonathan
    Schulze, Katja
    Price, Richard
    Patel, Arisha
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain Metastases
    Huang, Jie
    Zhu, Wenqiang
    Duan, Qiangzhi
    Zhu, Chaomang
    Shi, Xueling
    Zhao, Hongyu
    Cai, Peng
    Li, Duojie
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 841 - 853
  • [24] A phase 1 study of MM-111, a bispecific HER2/HER3 antibody fusion protein, combined with multiple treatment regimens in patients with advanced HER2-positive solid tumors.
    Richards, Donald A.
    Braiteh, Fadi S.
    Garcia, A. A.
    Denlinger, Crystal Shereen
    Conkling, Paul R.
    Edenfield, William Jeffery
    Anthony, Stephen Patrick
    Hellerstedt, Beth A.
    Raju, Robert N.
    Becerra, Carlos
    Harb, Wael A.
    Smith, David A.
    McDonagh, Charlotte Fenton
    Kawash, Kate-Lyn
    Frye, Sasha
    Moyo, Victor M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Pyrotinib in the treatment of women with advanced HER2 positive breast cancer: A multicenter, prospective, real world study
    Feng, Jifeng
    Zhang, Lili
    Guo, Zhaoji
    Zhou, Jun
    Zhu, Mingzhen
    Wu, Xiaohong
    Yi, Tongbo
    Guo, Yujiang
    Li, Xiaoqin
    Yu, Hao
    Mao, Weidong
    Gu, Bei
    Han, Zhengxiang
    Zuo, Yun
    Liu, Yanhua
    Wang, Xufen
    CANCER RESEARCH, 2021, 81 (04)
  • [26] A phase I and pharmacologic study of MM-111, a bispecific HER2/HER3 antibody fusion protein, in combination with multiple treatment regimens in patients with advanced HER2-positive solid tumors.
    Richards, Donald A.
    Braiteh, Fadi S.
    Anthony, Stephen Patrick
    Edenfield, Jeff
    Hellerstedt, Beth A.
    Raju, Robert N.
    Conkling, Paul
    Smith, David A.
    Becerra, Carlos
    Cohn, Allen Lee
    Denlinger, Crystal Shereen
    Garbo, Lawrence E.
    Wu, Hillary H.
    Garcia, Agustin
    McDonagh, Charlotte
    Frye, Sasha
    Agresta, Samuel V.
    Moyo, Victor M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Serum HER-2/neu levels in clinical studies with lapatinib in HER-2/neu positive breast cancer
    Maltzman, J.
    Blackwell, K.
    Stein, S.
    Martin, A.
    Westland, R.
    Burstein, H.
    Gomez, H.
    Gartner, N.
    Platek, G.
    Newmiller, M.
    Lipton, A.
    Carney, W. P.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A130 - A130
  • [28] Real-world incidence and management of diarrhea secondary to pyrotinib in patients with HER-2 positive breast cancer
    Liu, Hong
    Ma, Li
    Wang, Xu
    Chang, Xinzhong
    Yu, Qi
    Huang, Qingfeng
    Hao, Chunfang
    Liu, Jun
    Zhao, Jing
    Li, Shufen
    Tong, Zhongsheng
    Shi, Yehui
    Lu, Ning
    Zhao, Weipeng
    Wang, Tong
    Cao, Xuchen
    Wang, Chen
    Liu, Juntian
    Zhao, Ying
    Zhang, Lina
    Guo, Baoliang
    Wang, Xin
    Di, Xu
    Gao, Chunhui
    Liu, Zongzhan
    Sun, Shuo
    Li, Linwei
    CANCER RESEARCH, 2023, 83 (05)
  • [29] Efficacy and safety of pyrotinib in combination with albumin-bound paclitaxel for the treatment of HER2-positive advanced breast cancer: A real-world study
    Yang, Lixian
    Zheng, Lei
    Kong, Fanting
    Tian, Xinli
    Zhang, Shiyu
    Pu, Pengpeng
    ONCOLOGY LETTERS, 2023, 26 (01)
  • [30] Increasing Use of Neoadjuvant Treatment for T1 and T2 HER-2 Positive Tumors
    Al-Hilli, Zahraa
    Boughey, Judy
    Hoskin, Tanya
    Hieken, Tina J.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : 27 - 27
12345